In the event of a disaster in your area, make sure you can access emergency services.
Read News ArticleCategory: Latest News
In Memory of Robert Rapp
The entire staff at the Multiple Sclerosis Association of America (MSAA), as well as many of MSAA’s corporate partners, are mourning the loss of our former Chief Operating Officer and treasured colleague, Robert “Bob” Rapp. Following a successful career in education and public service, Bob joined the staff of MSAA as Director of Services in […]
Read News ArticleFDA Accepts Application for Cladribine Tablets
EMD Serono, Inc. announced today that the United States Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for Cladribine Tablets (an oral formulation of cladribine), an investigational treatment for relapsing forms of MS. Accepted by the European Commission in August 2017 and by Canada in December 2017, Cladribine is currently approved […]
Read News ArticleMSAA’s Publications Honored by the 30th Annual APEX Awards
The Multiple Sclerosis Association of America (MSAA) is proud to announce that we have received two awards from the 30th Annual APEX Awards for Publication Excellence! These were given for MSAA’s informative booklet, Understanding Progression in MS, and for the Summer/Fall 2017 edition of The Motivator. MSAA was presented with an Award of Excellence in […]
Read News ArticleResearch Highlights from the AAN and CMSC 2018 Annual Meetings
In this Article Disease-Modifying Therapies in the Research Pipeline Long-Term Efficacy and Safety of Approved DMTs Comparative Analyses of Approved DMTs New Diagnostic Testing Various Strategies for Wellness and Symptom Management, Physical Activity and Exercise, Vitamin D, and Reproductive-Health Topics Hot Topics in MS: Stem Cells, Lipoic Acid, Diet and MS, Obesity and MS, Gut […]
Read News ArticleMobile App Helps People with Multiple Sclerosis Better Manage Their Disease
My MS Manager™ is the Multiple Sclerosis Association of America’s mobile phone app designed to be a convenient and effective tool for members of the MS community to help manage their condition. The app, powered by @Point of Care, is available to download free of charge for both iOS and Android devices. Features available in […]
Read News ArticleMS Conversations, My MSAA Today, and The Motivator Recognized by 2018 Digital Health Awards
Three of MSAA’s free resources were recognized by the 2018 Digital Health Awards for their excellence in digital communication.
Read News ArticleMRI Access Fund Expanded to Help Members of the Multiple Sclerosis Community
The MRI Access Fund assists with the payment of cranial (brain) and c-spine MRI scans for qualified individuals who have no medical insurance or cannot afford their insurance costs. The exam must be required by a physician to help determine a diagnosis of multiple sclerosis or evaluate current MS disease progression.
Read News ArticleMSAA’s Blog and Mobile Phone App Recognized by Healthline
The Multiple Sclerosis Association of America (MSAA) is pleased to announce that our blog, MS Conversations, has been named one of the Best Multiple Sclerosis Blogs for the fourth consecutive year by Healthline!
Read News ArticleFDA Approves Gilenya® for Pediatric MS
On May 11, 2018, Novartis announced that Gilenya® (fingolimod) was approved by the United States Food and Drug Administration (FDA) for the treatment of children and adolescents, ages 10 through 17, with relapsing multiple sclerosis (MS). This is the first disease-modifying therapy (DMT) to be approved for this form of the disease in this age […]
Read News Article